1. Home
  2. ACIU vs PCYO Comparison

ACIU vs PCYO Comparison

Compare ACIU & PCYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACIU
  • PCYO
  • Stock Information
  • Founded
  • ACIU 2003
  • PCYO 1976
  • Country
  • ACIU Switzerland
  • PCYO United States
  • Employees
  • ACIU N/A
  • PCYO N/A
  • Industry
  • ACIU Biotechnology: Pharmaceutical Preparations
  • PCYO Water Supply
  • Sector
  • ACIU Health Care
  • PCYO Utilities
  • Exchange
  • ACIU Nasdaq
  • PCYO Nasdaq
  • Market Cap
  • ACIU 247.4M
  • PCYO 271.7M
  • IPO Year
  • ACIU 2016
  • PCYO N/A
  • Fundamental
  • Price
  • ACIU $1.48
  • PCYO $9.99
  • Analyst Decision
  • ACIU Strong Buy
  • PCYO
  • Analyst Count
  • ACIU 2
  • PCYO 0
  • Target Price
  • ACIU $12.00
  • PCYO N/A
  • AVG Volume (30 Days)
  • ACIU 192.5K
  • PCYO 57.5K
  • Earning Date
  • ACIU 05-12-2025
  • PCYO 04-09-2025
  • Dividend Yield
  • ACIU N/A
  • PCYO N/A
  • EPS Growth
  • ACIU N/A
  • PCYO 118.08
  • EPS
  • ACIU N/A
  • PCYO 0.59
  • Revenue
  • ACIU $30,136,397.00
  • PCYO $29,911,000.00
  • Revenue This Year
  • ACIU N/A
  • PCYO N/A
  • Revenue Next Year
  • ACIU $676.94
  • PCYO N/A
  • P/E Ratio
  • ACIU N/A
  • PCYO $16.99
  • Revenue Growth
  • ACIU 84.51
  • PCYO 58.85
  • 52 Week Low
  • ACIU $1.43
  • PCYO $8.94
  • 52 Week High
  • ACIU $4.98
  • PCYO $14.63
  • Technical
  • Relative Strength Index (RSI)
  • ACIU 24.24
  • PCYO 43.17
  • Support Level
  • ACIU $1.48
  • PCYO $9.81
  • Resistance Level
  • ACIU $1.62
  • PCYO $11.14
  • Average True Range (ATR)
  • ACIU 0.12
  • PCYO 0.47
  • MACD
  • ACIU -0.00
  • PCYO -0.01
  • Stochastic Oscillator
  • ACIU 9.43
  • PCYO 28.87

About ACIU AC Immune SA

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

About PCYO Pure Cycle Corporation

Pure Cycle Corp is a diversified land and water resource development company. It designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in two business segments namely Water and wastewater resource development and Land development. It generates maximum revenue from the Land development segment. The company's services include water production, storage, treatment, bulk transmission to retail distribution systems, wastewater collection and treatment, irrigation water treatment and transmission, construction management, billing, and collection. The land resource development segment includes all the activities necessary to develop and sell finished lots.

Share on Social Networks: